Oxaliplatin-related side effects: Characteristics and management

被引：236

作者：

Cassidy, J ^{[1
]}

Misset, JL

机构：

[1] Univ Aberdeen, Dept Med & Therapeut, Inst Med Sci, Aberdeen AB25 2ZD, Scotland

[2] Hop St Louis, Dept Oncol, Paris, France

来源：

SEMINARS IN ONCOLOGY | 2002年 / 29卷 / 05期

关键词：

D O I：

10.1053/sonc.2002.35524

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：11 / 20

页数：10

共 38 条

[1] Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients [J].

Bécouarn, Y ;

Ychou, M ;

Ducreux, M ;

Borel, C ;

Bertheault-Cvitkovic, F ;

Seitz, JF ;

Nasca, S ;

Nguyen, TD ;

Paillot, B ;

Raoul, JL ;

Duffour, J ;

Fandi, A ;

Dupont-André, G ;

Rougier, P .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) :2739-2744

[2] Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer [J].

BertheaultCvitkovic, F ;

Jami, A ;

Ithzaki, M ;

Brummer, PD ;

Brienza, S ;

Adam, R ;

Kunstlinger, F ;

Bismuth, H ;

Misset, JL ;

Levi, F .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (11) :2950-2958

[3]

BRIENZA S, 1995, P AN M AM SOC CLIN, V14, P209

[4]

BUECHELE T, 1998, P AN M AM SOC CLIN, V17, pA287

[5] Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer [J].

de Gramont, A ;

Figer, A ;

Seymour, M ;

Homerin, M ;

Hmissi, A ;

Cassidy, J ;

Boni, C ;

Cortes-Funes, H ;

Cervantes, A ;

Freyer, G ;

Papamichael, D ;

Le Bail, N ;

Louvet, C ;

Hendler, D ;

de Braud, F ;

Wilson, C ;

Morvan, F ;

Bonetti, A .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (16) :2938-2947

[6]

DEGARDIN M, 1997, JFORL, V46, P292

[7] Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48 hour continuous infusion in pretreated metastatic colorectal cancer [J].

deGramont, A ;

Vignoud, J ;

Tournigand, C ;

Louvet, C ;

Andre, T ;

Varette, C ;

Raymond, E ;

Moreau, S ;

LeBail, N ;

Krulik, M .

EUROPEAN JOURNAL OF CANCER, 1997, 33 (02) :214-219

[8] Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: A French intergroup study [J].

deGramont, A ;

Basset, JF ;

Milan, C ;

Rougier, P ;

Bouche, O ;

Etienne, PL ;

Morvan, F ;

Louvet, C ;

Guillot, C ;

Francois, E ;

Bedenne, L .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :808-815

[9]

DEGRAMONT A, 1998, P AN M AM SOC CLIN, V17, pA257

[10] PHASE-I STUDY OF OXALIPLATIN IN PATIENTS WITH ADVANCED CANCER [J].

EXTRA, JM ;

ESPIE, M ;

CALVO, F ;

FERME, C ;

MIGNOT, L ;

MARTY, M .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (04) :299-303

← 1 2 3 4 →